As shown in Table 1, there were no differences between patients in the CCL11 high-expression subgroup and low-expression subgroup in terms of age, gender, family history of cancer, previous low-grade tumor, extent of surgery, or diameter of tumor. The gene discussed is CCL11; the disease is neoplasm.